VFA 2010 (ARRA)
Ended Awarded Last action
- Contract number
- HHSD200201035149I
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2010N11987 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $261,469,025.27
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Glaxosmithkline Holdings (Americas) Inc. as the prime contractor. The contract has a ceiling value of $261,469,025.27 and a period of performance ending on June 30, 2011.
The purpose of this IDC is to provide adult vaccines, as part of the CDC's Adult Vaccine Contract 2010 - 2011 program. The contract was not set aside for any specific business category. It was awarded as a multiple award, meaning other vendors may have been selected to provide similar services. The funding for this contract comes from the 2010 Tax Allocation Schedule (TAS) under the Vaccination for Adults (VFA) 2010 program, which includes funding from the American Recovery and Reinvestment Act (ARRA). The specific products and services to be delivered under this contract and related task orders are not provided, but can be reasonably inferred to include the procurement of adult vaccines for the CDC's vaccination program.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$163 | |
| Supplemental Agreement for work within scope | -$145,468 | |
| Supplemental Agreement for work within scope | -$1,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $5,080,397 | |
| Supplemental Agreement for work within scope | $1,235,639 | |
| Supplemental Agreement for work within scope | $2,665,231 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $79,755 | |
| Supplemental Agreement for work within scope | $504,395 | |
| Supplemental Agreement for work within scope | $601,606 | |
| Supplemental Agreement for work within scope | $1,365,768 | |
| Supplemental Agreement for work within scope | $4,804,250 | |
| Supplemental Agreement for work within scope | $889,800 | |
| Original award | $7,349,383 |
Show all 16
Quick answers
Who was awarded contract HHSD200201035149I?
HHSD200201035149I was awarded to Glaxosmithkline Holdings (Americas) Inc. by CDC Office of Acquisition Services (Centers for Disease Control and Prevention) on July 1, 2010.
How much is contract HHSD200201035149I worth?
HHSD200201035149I's own ceiling is $261,469,025.
Who can order from contract HHSD200201035149I?
HHSD200201035149I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSD200201035149I part of a contract vehicle?
Yes. HHSD200201035149I is part of Adult Vaccine Contract 2010 - 2011.
Was contract HHSD200201035149I competed?
The extent of competition for HHSD200201035149I was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV